In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Morgan Lewis
- Kessler Topaz
- Gustafson Gluek
- Kirkland & Ellis
- Smith Segura Raphael & Leger
- Durrette Arkema
- Zelle LLP
- Garwin Gerstein
- DLA Piper
- Wilson Sonsini
- Lockridge Grindal
- Grabar Law
- McGuireWoods
- Winston & Strawn
- Crowell & Moring
- O'Hagan Meyer
- Ventker Henderson
- Boies Schiller
- Joseph Saveri Law Firm
- Williams & Connolly
- Kaufman & Canoles
- DurretteCrump
- Duncan & Allen
- Fisher & Phillips
- Faruqi & Faruqi
- Wexler Boley
- Motley Rice
- Glasser & Glasser
- Girard Sharp
- Woods Rogers
- Hagens Berman
- White & Case
- Katten Muchin
- Marcus & Shapira
- Willcox & Savage
- BoiesBattin
- The Office of Craig C. Reilly
- Gibson Dunn
- Nussbaum Law Group
- Crenshaw Ware
- Hartley LLP
- Heins Mills
- Furniss Davis
- Hangley Aronchick
- Taus Cebulash
- Goldman Ismail
- Radice Law Firm
- Cohen Milstein
- Sperling Kenny
- Miller Shah
- Wolcott Rivers
- Berger Montague
- Glancy Prongay
- Labaton Keller
Companies
- Albertsons Cos. Inc.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Merck & Co. Inc.
- McKesson Corp.
- Fraternal Order of Police
- Humana Inc.
- Giant Eagle Inc.
- Cencora Inc.
- CVS Health Corp.
- Health Net Inc.
- H.D. Smith LLC
- Glenmark Pharmaceuticals Ltd.
- Mutual Drug
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- Zydus Pharmaceuticals Inc.
- Wegmans Food Markets Inc.
- Centene Corp.
- The Kroger Co.
- Rite Aid Corp.
- H‑E‑B LP
Sectors & Industries:
-
November 02, 2018
Zetia MDL Buyers Maintain Merck's Generic Deal Was Illegal
A Virginia federal court shouldn't throw out multidistrict litigation accusing Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. of manipulating the generic drug market to keep prices of the cholesterol medication Zetia high, buyers of the drug urged, claiming they can prove antitrust violations.
-
October 12, 2018
Merck, Glenmark Tear Apart Zetia Pay-For-Delay MDL Claims
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. have asked a Virginia federal court to throw out three complaints in multidistrict litigation accusing them of entering into an illegal reverse-payment deal to keep a generic version of the cholesterol drug Zetia off the market.
-
July 30, 2018
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.
-
July 03, 2018
Direct Drug Purchasers Aim For Consolidation In Zetia MDL
A putative class of direct purchasers of the cholesterol drug Zetia asked a Virginia federal judge on Monday to consolidate their antitrust claims accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.